Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: Role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2′-deoxyguanosine DNA glycosylase 1

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 2, 2005, Pages 497-505

  Lee, Amanda J ^a,b   Hodges, Nikolas J ^a   Chipman, James K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 OXO 7,8 DIHYDRO 2' DEOXYGUANOSINE DNA GLYCOSYLASE 1; BIOLOGICAL MARKER; CYSTEINE; DEOXYRIBONUCLEOPROTEIN; DICHROMATE SODIUM; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; DNA GLYCOSYLTRANSFERASE; DNA REPAIR PROTEIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; SERINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MALE; NORMAL HUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OXIDATION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REDUCTION;

ADULT; CARCINOGENS, ENVIRONMENTAL; CHROMATES; CHROMIUM; COMET ASSAY; DEOXYGUANOSINE; DNA DAMAGE; DNA GLYCOSYLASES; FEMALE; GENOTYPE; HUMANS; LEUKOCYTES; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 13944270619     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0295     Document Type: Article

References (90)

1. IARC. Chromium, nickel and welding. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 49. Lyon: IARC; 1990.
2. Cohen MD, Kargacin B, Klein CB, Costa M. Mechanism of chromium carcinogenicity and toxicity. Crit Rev Toxicol 1993;23:255-81.
3. Waterhouse JAH. Cancer among chromium platers. Br J Cancer 1975;32:262.
4. Alderson MR, Rattan NS, Bidstrup L. Health of workmen in the chromate-producing industry in Britain. Br J Ind Med 1981;38:117-24.
5. Werfel U, Langen V, Eickhoff I, et al. Elevated DNA single-strand breakage frequencies in lymphocytes of welders exposed to chromium and nickel. Carcinogenesis 1998;19:413-8.
6. Hodges NJ, Ádám B, Lee AJ, Cross HJ, Chipman JK. Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo 2 deoxy guanosine formation and inter-individual variation. Mutagenesis 2001;16:467-74.
7. Gao M, Binks SP, Chipman JK, Levy LS, Braithwaite RA, Brown SS. Induction of DNA strand breaks in peripheral lymphocytes by soluble chromium compounds. Hum Exp Toxicol 1992;11:77-82.
8. Xu J, Manning FC, Patierno S. Preferential formation and repair of chromium-induced DNA adducts and DNA-protein cross-links in nuclear matrix DNA. Carcinogenesis 1994;15:1443-50.
9. Bridgewater LC, Manning FCR, Patierno SR. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand cross linking. Carcinogenesis 1994;15:2421-7.
10. Cupo DY, Werterhahn KE. Binding of chromium to chromatin and DNA from liver and kidney of rats. Cancer Res 1985;45:1146-51.
11. Snow ET. A possible role for chromium (III) in genotoxicity. Environ Health Perspect 1991;92:75-81.
12. Aiyer J, Borges KM, Floyd RA, Wetterhahn KE. Role of chromium(V), glutathionyl and hydroxyl radical intermediates in chromium(VI)-induced DNA damage. Toxicol Environ Chem 1989;22:135-48.
13. Shi X, Mao Y, Knapton AD, et al. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(VI)-mediated Fenton-like reaction. Carcinogenesis 1994;15:2475-8.
14. Ye J, Wang S, Leonard SS, et al. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J Biol Chem 1999;274:34974-80.
15. Wang S, Leonard SS, Ye J, Ding M, Shi, X. The role of hydroxyl radical as a messenger in CrVI-induced p53 activation. Am J Physiol Cell Physiol 2000;273:C868-83.
16. Singh J, Pritchard DE, Carlisle DL, et al. Internalisation of carcinogenic lead chromate particles by cultured normal lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol Appl Pharmacol 1999;161:240-8.
17. 4 mediates cellular responses via reactive oxygen species. Mol Cell Biochem 2004;225:171-9.
18. Collins AR, Duthie SJ, Dobson VL. Direct enzyme detection of endogenous base damage in human lymphocyte DNA. Carcinogenesis 1993;14:1733-5.
19. Blasiak J, Kowalik JA. Comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat Res 2000;469:135-45.
20. Trzeciak A, Kowalik J, Malecka-Panas E, Drzewoski J, Wojewódzka M, Ko TI. Genotoxicity of chromium in human gastric mucosa cells and peripheral blood lymphocytes evaluated by the single cell gel electrophoresis (comet) assay. Med Sci Monit 2000;6:24-9.
21. Blasiak J, Trzeciak A, Malecka-Panas E, et al. DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. Teratog Carcinog Mutagen 1999;19:19-31.
22. Merk O, Reiser K, Speit G. Analysis of chromate-induced DNA-protein crosslinks with the comet assay. Mutat Res 2000;471:71-80.
23. Liu K, Husler J, Ye J, et al. On the mechanism of Cr(VI)-induced Carcinogenesis: dose dependence of uptake and cellular response. Mol Cell Biochem 2001;222:221-9.
24. Ueno S, Kashimoto T, Susa N, et al. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol App Pharmacol 2001;170:56-62.
25. Amaral-Mendes JJ, Pluygers E. Use of biochemical and molecular biomarkers for cancer risk assessment in humans. In: Cogliano VI, Luebeck EG, Zapponi GA, editors. Perspectives on biologically based cancer risk assessment. NATO series on challenges of modern society, vol. 25. New York: Kluwer Academic/Plenum Publishers; 1999. p. 81-182.
26. Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000;21:517-24.
27. Standeven AM, Wetterhahn KE. Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem Res Toxicol 1991;4:616-25.
28. Pourahmad J, O'Brian PJ. Biological reactive intermediates that mediate chromium (VI) toxicity. Adv Exp Med Biol 2001;500:203-7.
29. Garcia JD, Jennette KW. Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate. J Inorg Biochem 1981;14:281-95.
30. Pickett CB. Glutathione S-transferases: gene structure, regulation, and biological function. Annu Rev Biochem 1989;8:743-64.
31. De Flora S, Serra D, Camoirano A, Zanacchi P. Metabolic reduction of chromium, as related to its carcinogenic properties. Biol Trace Elem Res 1989;21:179-87.
32. Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V. Reduction of chromium(VI) and its relationship to carcinogenesis. J Toxicol Environ Health B Crit Rev 1999;2:87-104.
33. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
34. Lee AJ, Hodges NJ, Chipman JK. The modified comet assay as a biomarker of sodium dichromate-induced oxidative DNA damage: optimisation and reproducibility. Biomarkers 2004;9:103-15.
35. Duez P, Dehon G, Kumps A, Dubois J. Statistics of the comet assay: a key to discriminate between genotoxic effects. Mutagenesis 2003;2:159-66.
36. Hartmann A, Agurell E, Beevers C, et al. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003;18:45-51.
37. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L. Multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-6.
38. Nair UJ, Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999;20:743-8.
39. Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997;75:69-75.
40. Hardie LJ, Briggs JA, Davidson LA, et al. The effect of OGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis 2000;21:167-72.
41. Lunn RM, Langlois RG, Gsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
42. Betti C, Davini T, Giannessi L, Loprieno N, Barale R. Microgel electrophoresis assay (comet test) and SCE analysis in humans. Mutat Res 1994;307:323-33.
43. Collins AR, Dušinská M, Franklin M, et al. Comet assay in human biomonitoring studies: reliability, validation and applications. Environ Mol Mutagen 1997;30:139-46.
44. Dhawan A, Mathur N, Seth PK. The effect of smoking and eating habits on DNA damage in Indian population as measured in the comet assay. Mutat Res 2001;474:121-8.
45. Møller P, Knudsen LE, Loft S, Wallin H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidemiol Biomarkers Prev 2000;9:1005-15.
46. Singh NP, Danner DB, Tice RR, Brant L, Schneider EL. DNA damage and repair with age in individual human lymphocytes. Mutat Res 1990;237:123-30.
47. Betti C, Davini T, Giannessi L, Loprieno N, Barale R. Comparative studies by comet test and SCE analysis in human lymphocytes from 200 healthy subjects. Mutat Res 1995;343:201-7.
48. Frenzilli G, Betti C, Davini T, et al. Evaluation of DNA damage in leukocytes of ex-smokers by single cell gel electrophoresis. Mutat Res 1997;375:117-23.
49. Møller P, Knudsen LE, Frentz G, Dybdahl M, Wallin H, Nexø BA. Seasonal variation of DNA and repair in patients with non-melanoma skin cancer and referents with and without skin cancer. Mutat Res 1998;407:25-34.
50. Štrám RJ. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effect. Environ Health Perspect 1998;106:231-9.
51. Wojewódzka M, Kruszewski M, Iwanenko T, Collins AR, Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation. Mutat Res 1998;416:21-35.
52. Van Zeeland AA, de Groot AJL, Hall J, Donato F. 8-Hydroxyydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat Res 1999;439:249-57.
53. Lodovici M, Casalini C, Cariaggi R, Michelucci L, Dolara P. Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic Biol Med 2000;28:13-7.
54. Giovannelli L, Saieva C, Masala G, et al. Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis 2002;23:1483-9.
55. Harzdorf C, Lewalter J. Analytical methodology for biological monitoring of chromium. Regul Toxicol Pharmacol 1997;26:S86-93.
56. Miksche LW, Lewalter J. Health surveillance and biological effect monitoring for chromium-exposed workers. Regul Toxicol Pharmacol 1997;26:S94-9.
57. Corbett GE, Dodge DG, O'Flaherty E, et al. In vitro reduction kinetics of hexavalent chromium in human blood. Environ Res 1998;78:7-11.
58. Zhang Q, Kluz T, Salnikow K, Costa M. Comparison of the cytotoxicity, cellular uptake, and DNA-protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three different individuals. Biol Trace Elem Res 2002;86:11-22.
59. Collins AR, Dušinská M, Horváthová E, Munro E, Savio M, Štetina R. Interindividual differences in repair of base oxidation, measured in vitro with the comet assay. Mutagenesis 2001;16:297-01.
60. 326. Mutat Res 2001;486:207-16.
61. Miller MC, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 2001;120:269-80.
62. Gunaratnam M, Grant MH. The role of glutathione reductase in the cytotoxicity of chromium (VI) in isolated rat hepatocytes. Chem Biol Int 2001;134:191-2.
63. Hazra TK, Izumi T, Maidt L, Floy RA, Mitra S. The presence of two distinct 8-oxoguanine repair enzymes in human cells: their potential complementary roles in preventing mutation. Nucleic Acids Res 1998;26:5116-22.
64. Thomas D, Scot AD, Barbet R, Padula M, Boiteux S. Inactivation of OGG1 increases the incidence of GC-TA transversions in Saccharomyces cerevisiae: evidence for endogenous oxidative damage to DNA in eukaryotic cells. Mol Gen Genet 1997;254:171-8.
65. Klungland A, Rosewell I, Hollenbach S, et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Nat Acad Sci U S A 1999;96:113300-5.
66. Osterod M, Hollenbach S, Hengstler JG, Barnes DE, Lindahl T, Epe B. Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1) deficient mice. Carcinogenesis 2001;22:1459-63.
67. Arai T, Kelly VP, Minowa O, Noda T, Nishimura S. High accumulation of oxidative DNA damage, 8-hydroxyguanine, in Mmh/OGG1 deficient mice by chronic oxidative stress. Carcinogenesis 2002;23:2005-10.
68. Epe B. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice. Biol Chem 2002;383:467-75.
69. Hollenbach S, Dhénaut A, Eckert I, Radicella JP, Epe B. Overexpression of OGG1 in mammalian cells: effects on induced and spontaneous oxidative DNA damage and mutagenesis. Carcinogenesis 1999;20:1863-8.
70. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001;3:597-609.
71. Boiteux S, Radicella JP. Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie 1999;81:59-67.
72. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000;377:1-8.
73. Elahi A, Zheng Z, Park J, Eyring K, MaCaffrey T, Lazarus, P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002;23:1229-34.
74. Sugimura H, Kohno T, Wakai K, et al. OGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1999;8:669-74.
75. Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in OGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001;95:140-3.
76. Kohno T, Shinmura K, Tosaka M, et al. Genetic polymorphisms and alternative splicing of the OGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998;16:3219-25.
77. 326) protein which is frequently found in human populations. Nucleic Acids Res 1999;27:4001-7.
78. Chen SK, Hsieh WA, Tsai MT, et al. Age-associated decrease of oxidative repair enyzmes human 8-oxoguanine DNA glycosylases (OGG1), in human aging. J Radiat Res 2003;44:31-5.
79. Tarng DC, Tsai TJ, Chen WT, Liu TY, Wei YH. Effect of human OGG1 1245C→G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J Am Soc Nephrol 2001;12:2338-47.
80. Blessing H, Kraus S, Heindl P, Bal W, Hartwig A. Interaction of selenium compounds with zinc finger proteins involved in DNA repair. Eur J Biochem 2004;15:3190-9.
81. Hartwig A, Asmuss M, Ehleben I, et al. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect 2002;110:797-9.
82. Dantzer F, Luna L, Bjørås M, Seeberg E. Human OGG1 undergoes serine phosphorylation and associates with the nuclear matrix and mitotic chromatin in vivo. Nucleic Acids Res 2002;30:2349-57.
83. Evans RM, Currie L, Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals and its relation to plasma concentration. Br J Nutr 1982;47:473-82.
84. Lenton KJ, Sane AT, Therriault H, Cantin AM, Payette H, Wagner JR. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr 2003;77:189-95.
85. Lehmann J, Rao DD, Canary JJ, Judd JT. Vitamin E and relationship among tocopherols in human plasma, platelets, lymphocytes and red blood cells. Am J Clin Nutr 1998;47:470-4.
86. Lenton KJ, Therriault H, Fulop T, Payette H, Wagner JR. Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis 1999;20:607-13.
87. Fillion L, Collins AR, Southon S. β-Carotene enhances the recovery of lymphocytes from oxidative DNA damage. Acta Biochim Pol 1998;45:183-90.
88. Collins AR, Olmedilla B, Southon S, Granado F, Duthie SJ. Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 1998;19:2159-62.
89. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996;56:1291-5.
90. Perez DD, Strobel P, Foncea R, et al. Wine, diet, antioxidant defenses and DNA damage. Ann N Y Acad Sci 2002;957:136-45.